BMS-094

Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers of recklessness
Fierce Biotech
Mon, 09/17/12 - 12:04 pm
R&D
Bristol-Myers Squibb
hepatitis C
BMS-094
Big Pharma Failures Light the Way to Change
Forbes
Thu, 08/16/12 - 10:10 am
Alzheimer's disease
Bristol-Myers Squibb
BMS-094
FDA
Rethinking Idenix Pharma in Wake of Bristol's Hep C Blow Up
TheStreet.com
Mon, 08/6/12 - 10:46 am
hepatitis C
Idenix
Bristol-Myers Squibb
BMS-094